Van Nostrand Robert L - Net Worth and Insider Trading

Van Nostrand Robert L Net Worth

The estimated net worth of Van Nostrand Robert L is at least $857,468 dollars as of 2024-11-13. Van Nostrand Robert L is the Director of Intra-Cellular Therapies Inc and owns about 9,690 shares of Intra-Cellular Therapies Inc (ITCI) stock worth over $857,468. Details can be seen in Van Nostrand Robert L's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Van Nostrand Robert L has not made any transactions after 2024-06-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Van Nostrand Robert L

To

Van Nostrand Robert L Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Van Nostrand Robert L owns 5 companies in total, including Yield10 Bioscience Inc (YTEN) , Intra-Cellular Therapies Inc (ITCI) , and SELLAS Life Sciences Group Inc (SLS) among others .

Click here to see the complete history of Van Nostrand Robert L’s form 4 insider trades.

Insider Ownership Summary of Van Nostrand Robert L

Ticker Comapny Transaction Date Type of Owner
YTEN Yield10 Bioscience Inc 2015-09-10 director
ITCI Intra-Cellular Therapies Inc 2024-06-18 director
SLS SELLAS Life Sciences Group Inc 2019-03-14 director
LIMIT LIMIT 2020-01-28 director
LIMIT LIMIT 2017-01-03 director

Van Nostrand Robert L Latest Holdings Summary

Van Nostrand Robert L currently owns a total of 1 stock. Van Nostrand Robert L owns 9,690 shares of Intra-Cellular Therapies Inc (ITCI) as of June 18, 2024, with a value of $857,468.

Latest Holdings of Van Nostrand Robert L

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ITCI Intra-Cellular Therapies Inc 2024-06-18 9,690 88.49 857,468

Holding Weightings of Van Nostrand Robert L


Van Nostrand Robert L Form 4 Trading Tracker

According to the SEC Form 4 filings, Van Nostrand Robert L has made a total of 4 transactions in Intra-Cellular Therapies Inc (ITCI) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Intra-Cellular Therapies Inc is the sale of 20,000 shares on June 18, 2024, which brought Van Nostrand Robert L around $2 Million.

Insider Trading History of Van Nostrand Robert L

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Van Nostrand Robert L Trading Performance

GuruFocus tracks the stock performance after each of Van Nostrand Robert L's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Van Nostrand Robert L is 45.37%. GuruFocus also compares Van Nostrand Robert L's trading performance to market benchmark return within the same time period. The performance of stocks bought by Van Nostrand Robert L within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Van Nostrand Robert L's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Van Nostrand Robert L

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 22.03 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 15.3 LIMIT LIMIT LIMIT LIMIT LIMIT

Van Nostrand Robert L Ownership Network

Ownership Network List of Van Nostrand Robert L

No Data

Ownership Network Relation of Van Nostrand Robert L

Insider Network Chart

Van Nostrand Robert L Owned Company Details

What does Yield10 Bioscience Inc do?

Who are the key executives at Yield10 Bioscience Inc?

Van Nostrand Robert L is the director of Yield10 Bioscience Inc. Other key executives at Yield10 Bioscience Inc include 10 percent owner Jack W Schuler , VP Planning and Comms Lynne H Brum , and VP Fin and CAO Charles B Haaser .

Yield10 Bioscience Inc (YTEN) Insider Trades Summary

Over the past 18 months, Van Nostrand Robert L made no insider transaction in Yield10 Bioscience Inc (YTEN). Other recent insider transactions involving Yield10 Bioscience Inc (YTEN) include a net purchase of 568,000 shares made by Jack W Schuler ,

In summary, during the past 3 months, insiders sold 0 shares of Yield10 Bioscience Inc (YTEN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 8,208 shares of Yield10 Bioscience Inc (YTEN) were sold and 31,875 shares were bought by its insiders, resulting in a net purchase of 23,667 shares.

Yield10 Bioscience Inc (YTEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Yield10 Bioscience Inc Insider Transactions

No Available Data

Van Nostrand Robert L Mailing Address

Above is the net worth, insider trading, and ownership report for Van Nostrand Robert L. You might contact Van Nostrand Robert L via mailing address: C/o Achillion Pharmaceuticals, Inc., 300 George Street, New Haven Ct 06511.